top of page

35+ YEARS IN MEDICAL DEVICE | PHARMACEUTICAL | BIOTECHNOLOGY | DIAGNOSTICS

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

Aro Biotherapeutics Announces Leadership Transition: Purnanand Sarma, Ph.D., Appointed as CEO

1 min read

Philadelphia, February 11, 2025 (Business Wire) -- Aro Biotherapeutics is undergoing a leadership transition, with co-founder Susan Dillon stepping down as CEO while remaining chair of the Board and an advisor. Purnanand Sarma has been appointed as the new CEO, bringing extensive industry experience to the role. The move underscores Aro’s focus on maintaining strategic momentum while leveraging strong leadership.

Read full article here.

Recent Posts

Abcuro Closes $200M Series C to Advance First-In-Class IBM Therapy Ulviprubart Toward Approval and Commercialization

Newton, MA, February 12, 2025 (Business Wire) -- Abcuro, Inc. has secured $200 million in Series C financing, led by New Enterprise...

Globus Medical Expands Neuromodulation Footprint with $250M Acquisition of Nevro

Audubon, PA, February 11, 2025 (finance yahoo) -- Globus Medical has signed a definitive agreement to acquire Nevro Corp. in an...

Baxter CEO José Almeida Retires; Brent Shafer Appointed Interim CEO

Deerfield, Ill, February 2, 2025 (Baxter) -- Baxter International announces the retirement of CEO José Almeida, effective immediately,...

Comments

Life Science Headlines

Abcuro Closes $200M Series C to Advance First-In-Class IBM Therapy Ulviprubart Toward Approval and Commercialization

Aro Biotherapeutics Announces Leadership Transition: Purnanand Sarma, Ph.D., Appointed as CEO

Globus Medical Expands Neuromodulation Footprint with $250M Acquisition of Nevro

Baxter CEO José Almeida Retires; Brent Shafer Appointed Interim CEO

Novartis Strengthens Cardiovascular Pipeline with $925M Acquisition of Anthos Therapeutics Acquisition

Neko Health Secures $260M in Series B Funding to Expand Healthcare Scanner Technology in the U.S. and Europe

Lyndra Therapeutics Appoints Adam Sayer as CEO to Drive Innovation in Long-Acting Oral Therapies

AbbVie Partners with Neomorph to Develop Novel Molecular Glue Degraders for Cancer and Immune Disorders, with Up to $1.64B in Potential Milestones

Masimo Appoints Katie Szyman as CEO

Zimmer Biomet to Acquire Paragon 28 for $1.1B, Expanding Orthopedic Surgical Portfolio

bottom of page